Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine

Reproductive Toxicology

Volumn 34, Issue 3, 2012, Pages 364-369

  Hoeltzenbein, Maria ^a   Weber Schoendorfer, Corinna ^a   Borisch, Cornelia ^a   Allignol, Arthur ^b   Meister, Reinhard ^c   Schaefer, Christof ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c BEUTH UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

6 Mercaptopurine; Azathioprine; Human; Malformation; Paternal; Pregnancy outcome; Spontaneous abortion; Teratogen

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MERCAPTOPURINE; MESALAZINE; PYRIDOSTIGMINE;

ABDOMINAL CAVERNOUS HEMANGIOMA; ARTICLE; AUTOIMMUNE DISEASE; BIRTH DEFECT; CHROMOSOME ABERRATION; COHORT ANALYSIS; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; CROHN DISEASE; CYSTIC FIBROSIS; DYSPRAXIA; ENVIRONMENTAL EXPOSURE; FABRY DISEASE; FEMALE; FETUS; GLANDULAR HYPOSPADIA; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEMANGIOMA; HIGH RISK PREGNANCY; HIP DYSPLASIA; HORSESHOE KIDNEY; HUMAN; HYDROCELE; HYDROCEPHALUS; INGUINAL HERNIA; KLINEFELTER SYNDROME; MAJOR CLINICAL STUDY; MALE; MOTOR RETARDATION; MYASTHENIA GRAVIS; OBSERVATIONAL STUDY; OPEN DUCTUS ARTERIOSUS; PATENT FORAMEN OVALE; PIGEON TOE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANT WOMAN; PROSPECTIVE STUDY; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; PYELECTASIS; SKIN TUMOR; SPONTANEOUS ABORTION; STILLBIRTH; TESTIS DESCENT; TRISOMY 18; TURNER SYNDROME; ULCERATIVE COLITIS; UMBILICAL HERNIA; XANTHOMA;

6-MERCAPTOPURINE; ADULT; AZATHIOPRINE; CONGENITAL ABNORMALITIES; FATHERS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84865546741     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.05.001     Document Type: Article

References (17)

1. Rajapakse R.O., Korelitz B.I., Zlatanic J., Baiocco P.J., Gleim G.W. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. American Journal of Gastroenterology 2000, 95:684-688.
2. Francella A., Dyan A., Bodian C., Rubin P., Chapman M., Present D.H. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003, 124:9-17.
3. Norgard B., Pedersen L., Jacobsen J., Rasmussen S.N., Sorensen H.T. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception. Alimentary Pharmacology and Therapeutics 2004, 19:679-685.
4. Teruel C., Lopez-San R.A., Bermejo F., Taxonera C., Perez-Calle J.L., Gisbert J.P., et al. Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. American Journal of Gastroenterology 2010, 105:2003-2008.
5. Schaefer C., Ornoy A., Clementi M., Meister R., Weber-Schoendorfer C. Using observational cohort data for studying drug effects on pregnancy outcome - methodological considerations. Reproductive Toxicology 2008, 26:36-41.
6. Merks J.H.M., Van Karnebeek K.C., Caron H.N., Hennekam R.C. Phenotypic abnormalities: terminology and classification. American Journal of Medical Genetics 2003, 123A:211-230.
7. Rasmussen S.A., Olney R.S., Holmes L.B., Lin A.E., Keppler-Noreuil K.M., Moore C.A. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Research Part A: Clinical and Molecular Teratology 2003, 67:193-201.
8. Voigt M., Rochow N., Hesse V., Olbertz D., Schneider K.T., Jorch G. Kurzmitteilung zu den Perzentilenwerten für die Körpermaße der Neugeborenen. Zeitschrift fur Geburtshilfe und Neonatologie 2010, 214:24-29.
9. Meister R., Schaefer C. Statistical methods for estimating the probability of spontaneous abortion in observational studies - analyzing pregnancies exposed to coumarin derivatives. Reproductive Toxicology 2008, 26:31-35.
10. Coscia L.A., Constantinescu S., Moritz M.J., Frank A., Ramirez C.B., Maley W.L., et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clinical Transplants 2009, 22-103.
11. Schaefer C., Meister R., Wentzeck R., Weber-Schoendorfer C. Fetal outcome after technetium scintigraphy in early pregnancy. Reproductive Toxicology 2009, 28:161-166.
12. Schaefer C., Meister R., Weber-Schoendorfer C. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy. Archives of Gynecology and Obstetrics 2010, 281:221-227.
13. Ben-Neriah Z., Ackermann Z. WAGR syndrome in a baby - the result of 6-MP treatment in a father affected by Crohn's disease?. American Journal of Gastroenterology 2001, 96:251.
14. Korelitz B.I., Rajapakse R.O., Zlatanic J., Baiocco P.J., Gleim G.W. 6MP for fathers with IBD at the time of conception: the value of a large clinical experience over unrelated controls. American Journal of Gastroenterology 2000, 95:2386-2387.
15. Martinez-Frias M.L., Rodriguez-Pinilla E. Problems of using data from Teratology Information Services (TIS) to identify putative teratogens. Teratology 1999, 60:54-55.
16. Ornoy A., Mastroiacovo P. More on data from teratogen information systems (TIS). Teratology 2000, 61:327-328.
17. Johnson K.A., Weber P.A., Jones K.L., Chambers C.D. Selection bias in Teratology Information Service pregnancy outcome studies. Teratology 2001, 64:79-82.